StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)

Close on Nov 17, 2026Market cap $88.39MP/E –Yield –

Stereotaxis r&d expenses

Research and development expenses are spending on new products and technology.

Stereotaxis's R&D Expenses for the twelve months ending Jun 30, 2026 was $10.04M, up 7.2% year over year. For fiscal 2025 it was $9.38M, down 3.9% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $14.26M in fiscal 2009.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.38M-3.9%
FY2024Dec 31, 2024$9.76M-5.0%
FY2023Dec 31, 2023$10.27M-2.7%
FY2022Dec 31, 2022$10.56M+3.5%
FY2021Dec 31, 2021$10.20M+25.3%
FY2020Dec 31, 2020$8.14M-9.8%
FY2019Dec 31, 2019$9.02M+9.8%
FY2018Dec 31, 2018$8.22M+22.6%
FY2017Dec 31, 2017$6.70M+22.2%
FY2016Dec 31, 2016$5.49M-12.2%
FY2015Dec 31, 2015$6.25M+21.2%
FY2014Dec 31, 2014$5.16M-9.1%
FY2013Dec 31, 2013$5.67M-32.5%
FY2012Dec 31, 2012$8.41M-34.8%
FY2011Dec 31, 2011$12.89M+5.2%
FY2010Dec 31, 2010$12.24M-14.1%
FY2009Dec 31, 2009$14.26M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.39M+34.5%
Q1 FY2026Mar 31, 2026$2.40M+2.0%
Q4 FY2025Dec 31, 2025$2.71M-2.9%
Q3 FY2025Sep 30, 2025$2.55M+3.7%
Q2 FY2025Jun 30, 2025$1.78M-21.8%
Q1 FY2025Mar 31, 2025$2.35M+4.8%
Q4 FY2024Dec 31, 2024$2.79M+26.1%
Q3 FY2024Sep 30, 2024$2.45M-8.0%
Q2 FY2024Jun 30, 2024$2.27M-14.1%
Q1 FY2024Mar 31, 2024$2.24M-18.3%
Q4 FY2023Dec 31, 2023$2.21M-7.8%
Q3 FY2023Sep 30, 2023$2.67M-5.3%
Q2 FY2023Jun 30, 2023$2.65M-8.5%
Q1 FY2023Mar 31, 2023$2.75M+12.2%
Q4 FY2022Dec 31, 2022$2.40M-8.2%
Q3 FY2022Sep 30, 2022$2.82M+12.7%
Q2 FY2022Jun 30, 2022$2.89M+6.5%
Q1 FY2022Mar 31, 2022$2.45M+3.4%
Q4 FY2021Dec 31, 2021$2.62M+24.6%
Q3 FY2021Sep 30, 2021$2.50M+28.0%
Q2 FY2021Jun 30, 2021$2.72M+37.4%
Q1 FY2021Mar 31, 2021$2.37M+12.2%
Q4 FY2020Dec 31, 2020$2.10M+29.8%
Q3 FY2020Sep 30, 2020$1.95M+11.5%
Q2 FY2020Jun 30, 2020$1.98M-26.6%
Q1 FY2020Mar 31, 2020$2.11M-28.7%
Q4 FY2019Dec 31, 2019$1.62M-27.3%
Q3 FY2019Sep 30, 2019$1.75M-12.5%
Q2 FY2019Jun 30, 2019$2.70M+32.6%
Q1 FY2019Mar 31, 2019$2.96M+50.8%
Q4 FY2018Dec 31, 2018$2.22M+28.7%
Q3 FY2018Sep 30, 2018$2.00M+23.5%
Q2 FY2018Jun 30, 2018$2.03M+15.7%
Q1 FY2018Mar 31, 2018$1.96M+22.6%
Q4 FY2017Dec 31, 2017$1.73M+33.1%
Q3 FY2017Sep 30, 2017$1.62M+25.1%
Q2 FY2017Jun 30, 2017$1.76M–
Q1 FY2017Mar 31, 2017$1.60M–
Q4 FY2016Dec 31, 2016$1.30M–
Q3 FY2016Sep 30, 2016$1.30M–

More Stereotaxis figures

See a number that looks wrong?